-
Dovitinib (TKI-258, CHIR-258) Assay Guide
2026-09-15
A scenario-based guide to using Dovitinib (TKI-258, CHIR-258), SKU A2168, in cell viability, proliferation, and apoptosis experiments. It connects low-nanomolar RTK pharmacology with practical stock preparation, assay compatibility, pathway validation, and vendor-selection criteria.
-
Transcription Condensates Safeguard Genome Stability
2026-09-15
The reference study identifies a cell-cycle timer that forms transcription condensates at histone locus bodies during the G1/S transition and removes them in mid-S phase through ATR-CHK1 signaling. This mechanism links linker histone expression to DNA replication and shows why failed condensate resolution can produce genome-wide DNA damage.
-
Brain-to-Spinal Control of Mechanical Allodynia
2026-09-14
The reference study identifies a contralateral lPBN Oprm1–dmH Pdyn–spinal dorsal horn pathway that regulates both the laterality and persistence of mechanical allodynia in mice. Its projection-defined perturbations show how descending inhibitory control can prevent contralateral pain hypersensitivity after nerve injury and shorten bilateral hypersensitivity after capsaicin exposure.
-
GLP-1 (9-36) Amide in Receptor Assays
2026-09-14
GLP-1 (9-36) amide is a glucagon-like peptide-1 receptor antagonist for dissecting cAMP-linked GPCR signaling. This guide moves beyond product description to show how assay architecture, receptor crosstalk, peptide handling, and orthogonal controls affect interpretation.
-
BI 2536 PLK1 Inhibitor: Workflow Guide
2026-09-13
BI 2536 combines subnanomolar PLK1 potency with a practical workflow for dissecting mitotic arrest, checkpoint control, and tumor-cell death. This guide connects dose-response experiments to the p31comet–TRIP13 checkpoint mechanism and highlights formulation, assay, and xenograft-model considerations.
-
Lovastatin Workflows for HMG-CoA Reductase Research
2026-09-12
Lovastatin connects mevalonate-pathway inhibition with practical assays for proliferation, apoptosis, wound remodeling, and macrophage efferocytosis. This workflow-focused guide explains solvent handling, dose design, model selection, and troubleshooting for reproducible HMG-CoA reductase research.
-
Rucaparib in DNA Damage Response Research
2026-09-12
Rucaparib (AG-014699) is a practical PARP1-directed tool for connecting DNA repair defects, radiation response, and cell-death phenotypes in cancer models. This workflow combines controlled compound handling with orthogonal DNA-damage and transcriptional readouts to distinguish repair failure from loss of transcription.
-
BIIE 0246: Y2R Antagonist Workflows
2026-09-11
BIIE 0246 enables selective interrogation of neuropeptide Y Y2 receptor signaling across synaptic, gastrointestinal, metabolic, and behavioral assays. This workflow-focused guide shows how to separate Y2R biology from the Y1R-centered adipose-neural arrhythmia pathway and optimize concentration, timing, controls, and interpretation.
-
CK2 and ERK8 Inhibitor: Research Guide
2026-09-11
The 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid compound is a small molecule inhibitor for research on CK2- and ERK8-dependent phosphorylation. Product documentation identifies B7464 as a 98.00% pure, DMSO-soluble research reagent, while SARS-CoV-2 condensate findings provide a separate framework for testing kinase effects on biomolecular organization.
-
ARCA Cy5 EGFP mRNA: Assay Design Guide
2026-09-10
ARCA Cy5 EGFP mRNA (5-moUTP) enables paired measurement of mRNA delivery and protein expression. This guide explains how to interpret Cy5 and EGFP signals, integrate controls, and connect reporter assays with modern mRNA-LNP workflows.
-
Vincristine Sulfate: An Assay-Design Framework
2026-09-10
Vincristine sulfate is a microtubule-targeting compound with broad value in cancer research. This guide connects its molecular pharmacology to exposure control, orthogonal assay design, and evidence-aware interpretation.
-
Neurospora crassa IPA Pathway and Auxin
2026-09-09
Sardar and Kempken provide the first integrated genetic and biochemical characterization of indole-3-pyruvic acid-mediated indole-3-acetic acid biosynthesis in the non-pathogenic fungus Neurospora crassa. Their results connect candidate pathway genes with metabolite profiles and conidiation phenotypes, establishing a useful framework for comparative auxin and fungal metabolism research.
-
Netarsudil (AR-13324) Assay Guide
2026-09-09
This scenario-based guide explains how Netarsudil (AR-13324), SKU B7807, can help researchers control ROCK-dependent cytoskeletal effects while avoiding misinterpretation of viability, proliferation, and siRNA-codelivery data. It covers assay design, solution preparation, data interpretation, and practical product-selection criteria.
-
FANCJ G4 Resolvase: Purification and Biochemical Analysis
2026-09-08
This Methods in Enzymology chapter presents an integrated workflow for purifying recombinant human FANCJ and testing its G-quadruplex resolvase and conventional duplex DNA helicase activities. Its main value is methodological: it connects defined DNA substrates, ATP-dependent motor activity, and disease-relevant interpretation in a framework that can be adapted to mechanistic DNA repair studies.
-
Alosetron in 5-HT3 and Intestinal Fate Research
2026-09-08
Alosetron is a selective 5-HT3 receptor antagonist for research on serotonin receptor pharmacology, gastrointestinal motility modulation, and visceral pain signaling. The cited intestinal study establishes a CDC42–YAP/TAZ–Ereg–mTOR mechanism, but it did not test Alosetron, so any connection between receptor blockade and epithelial stem-cell fate remains a testable research hypothesis.